Catalyst Wire Dossier Catalyst Wire Dossier

medical cannabis aerosol inhaled via Syqe Inhaler

cannabis aerosol inhalation · Syqe Medical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for medical cannabis aerosol inhaled via Syqe Inhaler, covering 2025-04-18 to 2025-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 2]

See pricing